Skip to main content
Log in

Quantitative Structure–Activity Relationship Analysis of Combretastatins: A Class of Novel Antimitotic Agents

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Combretastatins and their synthetic analogues, having structural features resembling that of colchicine, also have similar modes of action. In this report we have correlated the cytotoxicity of combretastatins against the murine leukemic cell line L1210 with physicochemical parameters such as the summation of the Hansch-Fujita π constant, which was used as an index of lipophilicity of the substituent groups on ring A (Σπa) and ring B (Σπb), the vector summation of the group dipole moments of ring A (Σµa) and ring B (Σµb), the nature of the linker chain between ring A and ring B (Bt-L), indicator parameters (NOH)a and (NOH)b, which represent the number of hydroxyl groups on ring A and ring B, respectively, and the summation of π values of the substituents on the linker (ΣπL). Cytotoxicity correlated well with (Σπb), (NOH)a, (Bt-L), and (Σµb), and the dependency on (Σπb) was found to be parabolic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. C. M. Lin, H. H. Ho, G. R. Pettit, and E. Hamel. Antimitotic natural products combretastatin A-4 and combretastatin A-2: Studies on the mechanism of their inhibition of the binding of colchicine to tubulin. Biochemistry 28:6984–6991 (1989).

    Google Scholar 

  2. C. M. Lin and E. Hamel. Interactions of Combretastatin, a new plant-derived antimitotic agent, with tubulin. Biochem. Pharmacol. 32:3864–3867 (1983).

    Google Scholar 

  3. G. R. Pettit, G. M. Cragg, D. L. Herald, J. M. Schmidt, and P. Lohavanijaya. Isolation and structure of combretastatin. Can. J. Chem. 60:1374–1376 (1982).

    Google Scholar 

  4. G. R. Pettit, S. B. Singh, E. Hamel, C. M. Lin, D. S. Alberts, and D. Garcia-Kendell. Isolation and structure of the Strong cell growth and tubulin inhibitor combretastatin A-4. Experientia 45:209–211 (1989).

    Google Scholar 

  5. K. Igarashi, S. Ikeyama, M. Takenchi, and Y. Sugino. Morphological changes in rat glioma cells caused by adenosine cyclic 3′-5′-monophosphate. Cell Struct. Funct. 3:103–112 (1978).

    Google Scholar 

  6. H. Schmidt and D. Atlas. Specific affinity labelling of tubulin with bromocolchicine. J. Mol. Biol. 102:743–758 (1976).

    Google Scholar 

  7. R. F. Williams, C. L. Mumford, G. A. Williams, L. J. Floyd, M. J. Aivaliotis, R. A. Martinez, A. K. Robinson, and L. D. Barnes. A photoaffinity derivative of colchicine [6′-(4′-azido-2′-nitrophenylamino)hexanoyldeacetylcolchicine]. Photo labelling and location of the colchicine-binding site on the α-subunit of tubulin. J. Biol. Chem. 260:13794–13802 (1985).

    Google Scholar 

  8. G. Sheir-Neiss, M. H. Lai, and N. R. Morris. Identification of a gene for the β-tubulin in Aspergillus nidulans. Cell 15:639–647 (1978).

    Google Scholar 

  9. F. Cabral, M. E. Sobel, and M. M. Gottesman. CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered β-tubulin. Cell 20:29–36 (1980).

    Google Scholar 

  10. R. A. B. Keates, F. Sarangi, and V. Ling. Structural and functional alterations in microtubule protein from Chinese hamster ovary cell mutants. Proc. Natl. Acad. Sci. USA 78:5638–5642 (1981).

    Google Scholar 

  11. H. Ponstingl, E. Krauhs, M. Little, and T. Kempf. Complete amino acid sequence of α-tubulin from porcine brain. Proc. Natl. Acad. Sci. USA 28:2757–2761 (1981).

    Google Scholar 

  12. E. Krauhs, E. Little, T. Kempf, R. Hofer-Warbinek, W. Ade, and H. Ponstingl. Complete amino acid sequence of β-tubulin from porcine brain. Proc. Natl. Acad. Sci. USA 78:4156–4160 (1981).

    Google Scholar 

  13. C. M. Lin, S. B. Singh, P. S. Chu, R. Dempcy, J. M. Schmidt, G. R. Pettit, and E. Hamel. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: A structure-activity study. Mol. Pharmacol. 34:200–208 (1988).

    Google Scholar 

  14. C. Hansch and A. Leo. Substituent Constants for the Correlation Analysis in Chemistry and Biology, 1st ed., Wiley, New York, 1979, Chap. III, pp. 13–17.

    Google Scholar 

  15. M. K. Wolpert-DeFillippes, V. H. Bono, Jr., R. L. Dion, and D. G. Johns. Initial studies on maytansine-induced metaphase arrest in L1210 murine leukemia cells. Biochem. Pharmacol. 24:1735–1738 (1975).

    Google Scholar 

  16. E. J. Lien. Remington's Pharmaceutical Sciences, 18th ed. Mack, Easton, PA, 1990, Chap. 13, pp. 158–181.

    Google Scholar 

  17. E. J. Lien, G. Z. Yang, and Z. R. Guo. Physical factors contributing to hydrophobic constant π. Quant. Struct. Act. Relat. 5:12–18 (1986).

    Google Scholar 

  18. W. Y. Li, Z. R. Guo, and E. J. Lien. Examination of the interrelationship between aliphatic group dipole moment and polar substituent constants. J. Pharm. Sci. 73:553 (1984).

    Google Scholar 

  19. E. J. Lien, Z. R. Guo, R. L. Li, and C. T. Su. Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure-activity relationship studies. J. Pharm. Sci. 71:641–655 (1982).

    Google Scholar 

  20. A. L. McClellan. Tables of Experimental Dipole Moments, Vol. 2, Rahara Enterprises, 8636 Don Carol Drive, El Cerrito, CA 94530, 1974.

    Google Scholar 

  21. BMDP Statistical Software Manual, 4th ed., BMDP Statistical Software, Los Angeles, 1987.

  22. G. R. Pettit, G. M. Cragg, and S. B. Singh. Antineoplastic agents, 122: Constituents of Combretum caffrum. J. Natl. Prod. 50:386–391 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nandy, P., Banerjee, S., Gao, H. et al. Quantitative Structure–Activity Relationship Analysis of Combretastatins: A Class of Novel Antimitotic Agents. Pharm Res 8, 776–781 (1991). https://doi.org/10.1023/A:1015814403997

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015814403997

Navigation